Corrigendum to “Forecasting of Oxidant/Antioxidant levels of COVID-19 patients by using Expert models with biomarkers used in the Diagnosis/Prognosis of COVID-19” [Int. Immunopharmacol. 100 (2021) 108127]

Detalles Bibliográficos
Autores principales: Huyut, Mehmet Tahir, Huyut, Zübeyir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier B.V. 2022
Materias:
Corrigendum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9671649/
https://www.ncbi.nlm.nih.gov/pubmed/36404254
http://dx.doi.org/10.1016/j.intimp.2022.109457
_version_ 1784832596445757440
author Huyut, Mehmet Tahir
Huyut, Zübeyir
author_facet Huyut, Mehmet Tahir
Huyut, Zübeyir
author_sort Huyut, Mehmet Tahir
collection PubMed
description
format Online
Article
Text
id pubmed-9671649
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Published by Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-96716492022-11-18 Corrigendum to “Forecasting of Oxidant/Antioxidant levels of COVID-19 patients by using Expert models with biomarkers used in the Diagnosis/Prognosis of COVID-19” [Int. Immunopharmacol. 100 (2021) 108127] Huyut, Mehmet Tahir Huyut, Zübeyir Int Immunopharmacol Corrigendum Published by Elsevier B.V. 2022-12 2022-11-18 /pmc/articles/PMC9671649/ /pubmed/36404254 http://dx.doi.org/10.1016/j.intimp.2022.109457 Text en © 2022 Published by Elsevier B.V. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Corrigendum
Huyut, Mehmet Tahir
Huyut, Zübeyir
Corrigendum to “Forecasting of Oxidant/Antioxidant levels of COVID-19 patients by using Expert models with biomarkers used in the Diagnosis/Prognosis of COVID-19” [Int. Immunopharmacol. 100 (2021) 108127]
title Corrigendum to “Forecasting of Oxidant/Antioxidant levels of COVID-19 patients by using Expert models with biomarkers used in the Diagnosis/Prognosis of COVID-19” [Int. Immunopharmacol. 100 (2021) 108127]
title_full Corrigendum to “Forecasting of Oxidant/Antioxidant levels of COVID-19 patients by using Expert models with biomarkers used in the Diagnosis/Prognosis of COVID-19” [Int. Immunopharmacol. 100 (2021) 108127]
title_fullStr Corrigendum to “Forecasting of Oxidant/Antioxidant levels of COVID-19 patients by using Expert models with biomarkers used in the Diagnosis/Prognosis of COVID-19” [Int. Immunopharmacol. 100 (2021) 108127]
title_full_unstemmed Corrigendum to “Forecasting of Oxidant/Antioxidant levels of COVID-19 patients by using Expert models with biomarkers used in the Diagnosis/Prognosis of COVID-19” [Int. Immunopharmacol. 100 (2021) 108127]
title_short Corrigendum to “Forecasting of Oxidant/Antioxidant levels of COVID-19 patients by using Expert models with biomarkers used in the Diagnosis/Prognosis of COVID-19” [Int. Immunopharmacol. 100 (2021) 108127]
title_sort corrigendum to “forecasting of oxidant/antioxidant levels of covid-19 patients by using expert models with biomarkers used in the diagnosis/prognosis of covid-19” [int. immunopharmacol. 100 (2021) 108127]
topic Corrigendum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9671649/
https://www.ncbi.nlm.nih.gov/pubmed/36404254
http://dx.doi.org/10.1016/j.intimp.2022.109457
work_keys_str_mv AT huyutmehmettahir corrigendumtoforecastingofoxidantantioxidantlevelsofcovid19patientsbyusingexpertmodelswithbiomarkersusedinthediagnosisprognosisofcovid19intimmunopharmacol1002021108127
AT huyutzubeyir corrigendumtoforecastingofoxidantantioxidantlevelsofcovid19patientsbyusingexpertmodelswithbiomarkersusedinthediagnosisprognosisofcovid19intimmunopharmacol1002021108127

Ejemplares similares